from a service provider's perspective
Keith A Grimaldi, Markus P Look, G Antonio Scioli, Juan Coll Clavero, Stathis Marinos and Tassos Tagaris
European Journal of Human Genetics 19, 382-388 (April 2011) | doi:10.1038/ejhg.2010.189
Abstract
The
purpose of this article is to give an overview and discuss the relevant
regulations in place, or under consideration, regarding
healthcare-related personal genetics services in Europe – this is a
rapidly evolving field and in most European Union (EU) countries the
regulatory framework is not yet clear. The review will be framed from
the perspective of potential service providers (companies, health
services and practitioners, including medical, nutritional,
complementary, etc), the growing number of which will need to be aware
of potential regulatory hurdles existing now and that may arise in the
future. The main conclusion from the survey is that strict regulations
regarding practitioner-delivered personal genetic-testing services are
unlikely to be enforced over the next 5 years in most EU countries, with
the exception of Germany. There is broad-based, but by no means
universal, support for a strong voluntary code of practice as an
alternative to government regulations to protect consumers and to enable
all stakeholders to recognise serious and reputable service providers.
On the other hand, there are influential bodies calling for strict
regulation. As genotyping costs rapidly fall, it is likely that it will
become routine and a major challenge that does not seem to be addressed
by current debate on regulations is the emergence of companies offering/selling
personal genetic services based on a customer's pre-existing genetic
results and therefore no actual laboratory testing involved.
Comments
Post has no comments.